Phase Holographic Imaging AB is a medical technology company specializing in non-invasive, time-lapse imaging instruments for long-term quantitative analysis of living cells. Its primary function is to provide leading-edge solutions for life science research, particularly in cancer, stem cell, and drug discovery fields. The company's innovative HoloMonitor system, based on Quantitative Phase Imaging (QPI) technology, enables label-free monitoring of cell morphology, migration, and proliferation without compromising cell integrity. This technology has profound implications for enhancing precision in cellular research and supporting advancements in regenerative medicine. Phase Holographic Imaging AB contributes significantly to the development of safer and more accessible cell therapies, positioning itself as a significant player in both pre-clinical research and clinical applications.
Markedsdata leveret af TwelveData og Morningstar